Literature DB >> 9573619

Three-dimensional structure of HIV-1 Rev protein filaments.

N R Watts1, M Misra, P T Wingfield, S J Stahl, N Cheng, B L Trus, A C Steven, R W Williams.   

Abstract

The HIV-1 Rev protein facilitates the export of incompletely spliced and unspliced viral mRNAs from the nucleus. Rev polymerizes into two types of filaments in vitro. In the presence of RNA, Rev forms poorly ordered structures, while in the absence of RNA it polymerizes into regular hollow filaments. We have determined the helical structure of the latter filaments by analysis of cryo-electron micrographs, taking into account STEM measurements of mass-per-unit-length. They are made up of Rev dimers, arranged in a six-start helix, with 31 dimers in 2 turns, a pitch angle of 45 degrees, and an interstrand spacing of 3.8 nm. Three-dimensional reconstruction at 2.1 nm resolution reveals a smooth outer surface and a featured inner surface, with outer and inner diameters of approximately 14.8 and approximately 10.4 nm, respectively. The Rev dimer has a "top-hat" shape with a cylinder approximately 3.2 nm in diameter and approximately 2.2 nm high, pointing inward: the thinner rim areas pack together to form the filament wall. Raman spectroscopy shows polymerized Rev to have approximately 54% alpha-helix and 20-24% beta-sheet content. Electron microdiffraction of aligned filaments reveals a broad meridional reflection at approximately (0.51 nm(-1, suggesting approximate alignment of the alpha-helices with the filament axis. Based on these data, a molecular model for the Rev filament is proposed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573619     DOI: 10.1006/jsbi.1998.3964

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  18 in total

1.  Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease.

Authors:  C Grégoire; S Marco; J Thimonier; L Duplan; E Laurine; J P Chauvin; B Michel; V Peyrot; J M Verdier
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element.

Authors:  Michael A DiMattia; Norman R Watts; Stephen J Stahl; Christoph Rader; Paul T Wingfield; David I Stuart; Alasdair C Steven; Jonathan M Grimes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes.

Authors:  Matthew D Daugherty; David S Booth; Bhargavi Jayaraman; Yifan Cheng; Alan D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

4.  Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.

Authors:  Thomas Vercruysse; Sonalika Pawar; Wim De Borggraeve; Els Pardon; George N Pavlakis; Christophe Pannecouque; Jan Steyaert; Jan Balzarini; Dirk Daelemans
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

5.  Over-expression of the HIV-1 Rev promotes death of nondividing eukaryotic cells.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Virus Genes       Date:  2010-02-12       Impact factor: 2.332

6.  A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.

Authors:  Xiaolei Zhuang; Stephen J Stahl; Norman R Watts; Michael A DiMattia; Alasdair C Steven; Paul T Wingfield
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

7.  An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production.

Authors:  Thomas Vercruysse; Els Pardon; Els Vanstreels; Jan Steyaert; Dirk Daelemans
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

8.  Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins.

Authors:  Aviad Levin; Joseph Rosenbluh; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Mol Med       Date:  2009-10-29       Impact factor: 6.354

9.  Generation and use of antibody fragments for structural studies of proteins refractory to crystallization.

Authors:  Stephen J Stahl; Norman R Watts; Paul T Wingfield
Journal:  Methods Mol Biol       Date:  2014

10.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.